What is Lifecore Biomedical, Inc.'s R&D?

Lifecore Biomedical, Inc. (LFCR) reported R&D of $1.22M in Q1 2026.

How has Lifecore Biomedical, Inc.'s R&D changed year-over-year?

Lifecore Biomedical, Inc.'s R&D decreased by 42.1% year-over-year, from $2.1M to $1.22M.

What is the long-term trend for Lifecore Biomedical, Inc.'s R&D?

Over 3 years (2022 to 2025), Lifecore Biomedical, Inc.'s R&D has grown at a 2.2% compound annual growth rate (CAGR), from $7.74M to $8.26M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Lifecore Biomedical, Inc. LFCR R&D

R&D at other companies

Baxter InternationalBAX

$139M-0.7%

Thermo Fisher ScientificTMO

$336M-1.8%

ADMA BiologicsADMA

$2.6M+214%

Biodesix, Inc.BDSX

$3.29M+14.5%

ClearPoint NeuroCLPT

$4.52M+33.8%

West Pharmaceutical ServicesWST

$15.8M-3.1%

Other financials

Income statement

See full

Revenue$23.2M-36.4%

Gross profit$4.5M-68.1%

Operating income-$4.7M—

Net income-$15.0M-1,206%

EPS (diluted)-$0.43-1,333%

Balance sheet

See full

Cash & equivalents$20.8M+152%

Total debt$156.9M+1,310%

Total equity-$28.4M-2,229%

Total assets$225.5M-5.8%

Cash flow

See full

Operating cash flow$4.7M—

CapEx$1.1M-46.7%

Free cash flow$3.6M—

Valuation

See full

Market cap$196.92M-37.3%

Enterprise value$333.06M+6.3%

P/S1.6×+0.5×

Profitability

See full

Gross margin31.3%-1.4pp

Operating margin-14.5%-2.2pp

Net margin-30%—

FCF margin-36.4%—

Returns & leverage

See full

Return on equity-612.1%—

Debt / equity8.3×-1.5×

Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s R&D?: Lifecore Biomedical, Inc. (LFCR) reported R&D of $1.22M in Q1 2026.
How has Lifecore Biomedical, Inc.'s R&D changed year-over-year?: Lifecore Biomedical, Inc.'s R&D decreased by 42.1% year-over-year, from $2.1M to $1.22M.
What is the long-term trend for Lifecore Biomedical, Inc.'s R&D?: Over 3 years (2022 to 2025), Lifecore Biomedical, Inc.'s R&D has grown at a 2.2% compound annual growth rate (CAGR), from $7.74M to $8.26M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.